Geode Capital Management’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-880,546
| Closed | -$5.14M | – | 4570 |
|
|
2025
Q1 | $5.14M | Buy |
880,546
+52,526
| +6% | +$277K | ﹤0.01% | 2639 |
|
|
2024
Q4 | $3.08M | Sell |
828,020
-7,184
| -0.9% | -$33.2K | ﹤0.01% | 2973 |
|
|
2024
Q3 | $4.67M | Buy |
835,204
+612
| +0.1% | +$4.28K | ﹤0.01% | 2791 |
|
|
2024
Q2 | $7.03M | Buy |
834,592
+34,064
| +4% | +$363K | ﹤0.01% | 2547 |
|
|
2024
Q1 | $11.6M | Buy |
800,528
+31,875
| +4% | +$527K | ﹤0.01% | 2239 |
|
|
2023
Q4 | $16.5M | Buy |
768,653
+39,079
| +5% | +$697K | ﹤0.01% | 2031 |
|
|
2023
Q3 | $14M | Buy |
729,574
+27,869
| +4% | +$594K | ﹤0.01% | 2050 |
|
|
2023
Q2 | $17.8M | Buy |
701,705
+42,992
| +7% | +$1.24M | ﹤0.01% | 1929 |
|
|
2023
Q1 | $23.8M | Buy |
658,713
+31,475
| +5% | +$1.11M | ﹤0.01% | 1675 |
|
|
2022
Q4 | $24.8M | Buy |
627,238
+21,847
| +4% | +$908K | ﹤0.01% | 1629 |
|
|
2022
Q3 | $28.2M | Buy |
605,391
+14,417
| +2% | +$669K | ﹤0.01% | 1502 |
|
|
2022
Q2 | $25.9M | Sell |
590,974
-9,180
| -2% | -$505K | ﹤0.01% | 1570 |
|
|
2022
Q1 | $43.4M | Buy |
600,154
+28,200
| +5% | +$2.03M | 0.01% | 1354 |
|
|
2021
Q4 | $46.4M | Buy |
571,954
+10,053
| +2% | +$1.01M | 0.01% | 1363 |
|
|
2021
Q3 | $65.4M | Sell |
561,901
-20,695
| -4% | -$2.71M | 0.01% | 1048 |
|
|
2021
Q2 | $96.6M | Buy |
582,596
+24,410
| +4% | +$3.81M | 0.01% | 805 |
|
|
2021
Q1 | $77.9M | Buy |
558,186
+44,675
| +9% | +$7.29M | 0.01% | 905 |
|
|
2020
Q4 | $88.9M | Buy |
513,511
+28,714
| +6% | +$4.65M | 0.01% | 758 |
|
|
2020
Q3 | $67.5M | Sell |
484,797
-10,205
| -2% | -$1.36M | 0.01% | 768 |
|
|
2020
Q2 | $59.1M | Buy |
495,002
+53,683
| +12% | +$6.37M | 0.01% | 807 |
|
|
2020
Q1 | $44.1M | Buy |
441,319
+35,587
| +9% | +$4.28M | 0.01% | 829 |
|
|
2019
Q4 | $47.7M | Buy |
405,732
+26,664
| +7% | +$2.64M | 0.01% | 968 |
|
|
2019
Q3 | $32.6M | Buy |
379,068
+10,308
| +3% | +$780K | 0.01% | 1141 |
|
|
2019
Q2 | $23.9M | Buy |
368,760
+28,306
| +8% | +$1.76M | 0.01% | 1360 |
|
|
2019
Q1 | $21.3M | Buy |
340,454
+31,459
| +10% | +$1.48M | 0.01% | 1372 |
|
|
2018
Q4 | $12M | Buy |
308,995
+26,356
| +9% | +$1.17M | ﹤0.01% | 1665 |
|
|
2018
Q3 | $16.1M | Buy |
282,639
+18,202
| +7% | +$1.14M | ﹤0.01% | 1569 |
|
|
2018
Q2 | $21.1M | Buy |
264,437
+23,015
| +10% | +$1.91M | 0.01% | 1307 |
|
|
2018
Q1 | $20.9M | Buy |
241,422
+5,539
| +2% | +$447K | 0.01% | 1230 |
|
|
2017
Q4 | $16.3M | Buy |
235,883
+1,428
| +0.6% | +$114K | 0.01% | 1426 |
|
|
2017
Q3 | $21.3M | Buy |
234,455
+47,633
| +25% | +$4.08M | 0.01% | 1190 |
|
|
2017
Q2 | $13.9M | Buy |
186,822
+11,056
| +6% | +$886K | 0.01% | 1456 |
|
|
2017
Q1 | $16.5M | Buy |
175,766
+11,404
| +7% | +$1.03M | 0.01% | 1296 |
|
|
2016
Q4 | $11.9M | Buy |
164,362
+12,651
| +8% | +$1.08M | 0.01% | 1459 |
|
|
2016
Q3 | $15.8M | Buy |
151,711
+48,149
| +46% | +$4.35M | 0.01% | 1169 |
|
|
2016
Q2 | $7.64M | Buy |
103,562
+13,895
| +15% | +$943K | ﹤0.01% | 1635 |
|
|
2016
Q1 | $5.04K | Buy |
89,667
+1,907
| +2% | +$112K | ﹤0.01% | 1861 |
|
|
2015
Q4 | $5.92M | Buy |
87,760
+4,661
| +6% | +$250K | ﹤0.01% | 1750 |
|
|
2015
Q3 | $3.85M | Buy |
83,099
+1,871
| +2% | +$90.7K | ﹤0.01% | 2008 |
|
|
2015
Q2 | $4.37M | Buy |
81,228
+35,865
| +79% | +$1.83M | ﹤0.01% | 1977 |
|
|
2015
Q1 | $2.17M | Buy |
45,363
+27,811
| +158% | +$1.21M | ﹤0.01% | 2383 |
|
|
2014
Q4 | $678K | Buy |
+17,552
| New | +$553K | ﹤0.01% | 3043 |
|
Other funds holding NVRO
Geode Capital Management's NVRO Position: Q2 2025 in Review
Geode Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 880,546 shares — an estimated $5.14M sold.
Geode Capital Management first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $96.6M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Geode Capital Management reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Geode Capital Management sold 880,546 NEVRO CORP. shares in Q2 2025, an estimated $5.14M.
- Geode Capital Management first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
- Geode Capital Management's NEVRO CORP. position peaked at $96.6M in Q2 2021.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.